Skip to main content
. 2012 Sep 4;12:205. doi: 10.1186/1471-2334-12-205

Table 2.

Clinical manifestations, laboratory data, and outcome of 670 meningococcal disease patients with completed case records: serogroup CversusA

Feature Serogroup C (n = 493) Serogroup A (n = 177)   P
onset
 
 
 
 
  Presentation days (mean ± SD)
1.8 ± 2.5
1.9 ± 2.4
 
0.810
  Fever
481(97.6)
169(95.5)
 
0.162
  Nausea and/or vomiting
141(28.5)
55(31.2)
 
0.535
  Headache
165(33.4)
52(29.1)
 
0.319
  Petechia and/or purpura
396(80.3)
126(73.4)
 
0.063
  Altered mental status
136(27.6)
49(27.7)
 
0.980
Disease classification
 
 
 
 
  Meningitis
114(23.1)
92(52.0)
 
<0.001
  Meningococcemia
379(76.9)
85(48.0)
 
 
  With Shock
91(18.5)
13(7.3)
 
<0.001
  With pneumonia
12(2.8)
3(1.7)
 
0.784
  With arthritis
9 (1.8)
4(2.3)
 
0.967
Complications
161
23
 
<0.001
  Shock
91(18.5)
13(7.3)
 
<0.001
  DIC
60(12.2)
7(4.0)
 
0.002
  kidney failure
10(2)
3(1.7)
 
0.783
  MOF
4(0.8)
1(0.6)
 
1.0
WBC count
 
 
 
 
  >10 × 109/L
302(61.3)
99(56.1)
 
0.019
  10~4 × 109/L
117(23.7)
35(19.8)
 
 
  <4 × 109/L
74(15.0)
43(24.3)
 
 
Platelet count
 
 
 
 
  >100 × 109/L
361(73.2)
162(91.5)
 
<0.001
  100~50 × 109/L
87(17.6)
11(6.2)
 
 
  100~50 × 109/L
87(17.6)
11(6.2)
 
 
CSF data (mean ± SD)
 
 
 
 
  Glucose level(mmol/L)
2.07 ± 1.7
1.91 ± 1.8
 
0.717
  CSF glucose / blood glucose ratio
0.24 ± 0.23
0.21 ± 0.29
 
0.438
  Total protein level(g/L)
3.41 ± 2.9
3.17 ± 2.18
 
0.106
  Lactate level(mmol/L)
10.4 ± 9.2
11.0 ± 8.9
 
0.113
  WBC count(109/L)
5.3 ± 13.8
8.1 ± 13.6
 
0.895
Sequelae
46/484(9.5)
6/171(3.5)
 
0.013
  Scars
19/484(3.9)
2/171(1.2)
 
0.132
  Amputations
14/484(2.9)
0
 
0.026
  sensorineural hearing loss
5/484(1.0)
3/171(1.8)
 
0.739
  Others
8/484(17)
1/171(0.6)
 
0.516
Death 55/484(11.4) 9/171(5.3)   0.021

NOTE. Data are no. (%) of patients, unless otherwise indicated.

WBC: white blood cells. DIC: disseminated intravascular coagulation.

MOF: multiple organ failure.